Showing results (1-10 of 124) with videos related to
Sort By:
Pageof 13
BMC Neuroscience|July 27, 2016
3-O-Methyldopa inhibits astrocyte-mediated dopaminergic neuroprotective effects of L-DOPAMasato Asanuma, Ikuko MiyazakiNihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|January 4, 2021
[Anti-oxidants in astrocytes as target of neuroprotection for Parkinson's disease]Masato Asanuma, Ikuko MiyazakiCells|December 10, 2020
Neuron-Astrocyte Interactions in Parkinson's DiseaseIkuko Miyazaki, Masato AsanumaExpert Review of Neurotherapeutics|October 3, 2006
Nonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formationMasato Asanuma, Ikuko MiyazakiCurrent Pharmaceutical Design|July 13, 2017
Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's DiseaseIkuko Miyazaki, Masato AsanumaCurrent Pharmaceutical Design|June 10, 2008
Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's diseaseMasato Asanuma, Ikuko MiyazakiAntioxidants (Basel, Switzerland)|April 28, 2023
Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson's DiseaseIkuko Miyazaki, Masato AsanumaInternational Journal of Molecular Sciences|August 27, 2021
Glutathione and Related Molecules in ParkinsonismMasato Asanuma, Ikuko MiyazakiNihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|March 1, 2021
[Therapeutic strategy for Parkinson's disease: targeting zinc-binding protein in astrocytes]Ikuko Miyazaki, Masato AsanumaActa Medica Okayama|July 4, 2008
Dopaminergic neuron-specific oxidative stress caused by dopamine itselfIkuko Miyazaki, Masato AsanumaPageof 13